PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Johnson & Johnson Surgical Vision, Inc.

USPTO PatentsView assignee record - 236 granted patents across 56 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Explore the portfolio See the ranking
236
Total patents granted
56
CPC technology areas
14.5
Avg claims per patent
+221%
5-year filing velocity

The verdict

Johnson holds 236 US patents across 56 technology areas, rank #1,731 of 50,000 tracked assignees.

#1,731
of 50,000 US assignees by volume
Top 4%
by Innovation Score (58.5/100)
14.5
avg claims per patent
+221%
filing velocity, last 5 yrs

Portfolio overview

Johnson & Johnson Surgical Vision, Inc. has been granted 236 US utility patents between 2018 and 2025, placing Johnson & Johnson Surgical Vision, Inc. at rank #1,731 across all assignees tracked by PlainPatent. This portfolio spans 56 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.5 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Johnson & Johnson Surgical Vision, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Johnson sits between University Of Louisville Research Foundation, Inc. (237 patents, rank #1,727) and Brigham Young University (235 patents, rank #1,735) - the closest US assignees by grant volume. The composite Innovation Score of 58.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 180 grants, compared with 56 in the 2015–2019 window, a +221% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Johnson & Johnson Surgical Vision, Inc.'s 14.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 56 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Johnson & Johnson Surgical Vision, Inc. against peers pursuing similar technology classes.

Who files at Johnson's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Johnson holds 236 patents at rank #1,731, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Johnson

By rank, the assignees closest to #1,731 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Johnson's primary technology class.

Johnson's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

58 Top 4% higher than 96% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

152025303540 20182019202020212022202320242025 26
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Johnson & Johnson Surgical Vision, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 18 7.6%
2019 38 16.1%
2020 26 11.0%
2021 38 16.1%
2022 28 11.9%
2023 24 10.2%
2024 38 16.1%
2025 26 11.0%

Which technologies does Johnson & Johnson Surgical Vision, Inc. patent most?

Top 15 of 56 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#1,731

Across all tracked assignees

Innovation Score

58.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Johnson & Johnson Surgical Vision, Inc. hold?
Johnson & Johnson Surgical Vision, Inc. holds 236 US granted patents filed between 2018 and 2025, spanning 56 technology areas.
What is Johnson & Johnson Surgical Vision, Inc.'s Innovation Score?
Johnson & Johnson Surgical Vision, Inc. has an Innovation Score of 58.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Johnson & Johnson Surgical Vision, Inc. focus on?
Johnson & Johnson Surgical Vision, Inc.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 194 patents. The company has filed patents in 56 CPC subclasses total.
Is Johnson & Johnson Surgical Vision, Inc.'s patent filing rate increasing or decreasing?
Johnson & Johnson Surgical Vision, Inc.'s recent filing velocity is +221% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Johnson & Johnson Surgical Vision, Inc.'s patents?
Johnson & Johnson Surgical Vision, Inc.'s patents average 14.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the Johnson & Johnson Surgical Vision, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Johnson's 236 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Johnson ranks #1,731 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.